Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 02, 2022

SELL
$219.27 - $242.57 $1.23 Million - $1.36 Million
-5,609 Closed
0 $0
Q4 2021

Feb 02, 2022

BUY
$198.88 - $227.6 $45,941 - $52,575
231 Added 4.3%
5,609 $1.26 Million
Q3 2021

Nov 12, 2021

SELL
$212.27 - $248.7 $8,278 - $9,699
-39 Reduced 0.72%
5,378 $1.14 Million
Q2 2021

Jul 23, 2021

BUY
$233.58 - $259.14 $16,117 - $17,880
69 Added 1.29%
5,417 $1.32 Million
Q1 2021

May 06, 2021

SELL
$221.91 - $258.6 $26,629 - $31,032
-120 Reduced 2.19%
5,348 $1.33 Million
Q4 2020

Feb 05, 2021

BUY
$216.38 - $257.67 $21,638 - $25,767
100 Added 1.86%
5,468 $1.26 Million
Q3 2020

Nov 13, 2020

SELL
$234.65 - $260.95 $25,811 - $28,704
-110 Reduced 2.01%
5,368 $1.36 Million
Q2 2020

Aug 11, 2020

BUY
$197.81 - $242.74 $11,868 - $14,564
60 Added 1.11%
5,478 $1.29 Million
Q1 2020

Apr 30, 2020

BUY
$182.24 - $241.7 $1,457 - $1,933
8 Added 0.15%
5,418 $1.1 Million
Q4 2019

Feb 03, 2020

SELL
$189.21 - $243.2 $39,734 - $51,072
-210 Reduced 3.74%
5,410 $1.3 Million
Q3 2019

Oct 24, 2019

SELL
$174.11 - $208.62 $17,411 - $20,862
-100 Reduced 1.75%
5,620 $1.09 Million
Q2 2019

Jul 30, 2019

SELL
$166.7 - $195.41 $69,180 - $81,095
-415 Reduced 6.76%
5,720 $1.05 Million
Q1 2019

May 03, 2019

SELL
$180.87 - $203.88 $158,261 - $178,395
-875 Reduced 12.48%
6,135 $1.17 Million
Q4 2018

Feb 06, 2019

SELL
$178.4 - $208.25 $40,140 - $46,856
-225 Reduced 3.11%
7,010 $1.37 Million
Q3 2018

Nov 14, 2018

BUY
$185.29 - $208.89 $2,779 - $3,133
15 Added 0.21%
7,235 $1.5 Million
Q2 2018

Aug 03, 2018

SELL
$166.05 - $186.51 $33,210 - $37,302
-200 Reduced 2.7%
7,220 $1.33 Million
Q1 2018

May 29, 2018

SELL
$169.43 - $198.0 $14,401 - $16,830
-85 Reduced 1.13%
7,420 $1.27 Million
Q4 2017

Feb 09, 2018

SELL
$168.79 - $188.59 $84,395 - $94,295
-500 Reduced 6.25%
7,505 $1.31 Million
Q3 2017

Nov 06, 2017

BUY
$167.29 - $191.0 $1.34 Million - $1.53 Million
8,005
8,005 $1.49 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $171B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Trust Investment Advisors Portfolio

Follow Trust Investment Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trust Investment Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Trust Investment Advisors with notifications on news.